Effects of a weight reduction program with and without aerobic exercise in the metabolic syndrome

International Journal of Cardiology
Michael ChristWolfram Grimm

Abstract

In the setting of a rural, primary care practice, evidence for the efficacy of intentional weight loss with or without aerobic exercise training (AET) in hypertensive patients with the metabolic syndrome remains controversial. DESIGN OF STUDY, METHODS: We analysed data of 52 hypertensives with the metabolic syndrome, who attended a weight management program with or without AET (diet/exercise group, n = 18; diet group, n = 20) for 36 months. Patients with a similar risk profile, who declined antihypertensive therapy beyond ACE inhibition, served as controls (n = 14). Body mass index (BMI) was significantly reduced over time in the diet and diet/exercise group (DeltaBMI: -7.2 +/- 1.1 and -6.6 +/- 1.5 kg/m2) vs. the control group (DeltaBMI: +0.4 +/- 1.3 kg/m2; p < 0.001 at 36 m). While systolic and diastolic blood pressures (BPs) did not change over time in controls (175 +/- 5/89 +/- 7 mm Hg), BPs were significantly reduced in the diet group (151 +/- 8/75 +/- 10 mm Hg) and in the diet/exercise group (139 +/- 12/71 +/- 8 mm Hg; p < 0.001 vs. diet group). Metabolic abnormalities were significantly improved over time in the diet group vs. controls, while AET did not add further benefits. However, heart rate recovery after acute exerc...Continue Reading

References

Aug 1, 1992·The American Journal of Clinical Nutrition·A M Dattilo, P M Kris-Etherton
Dec 14, 1991·BMJ : British Medical Journal·L E RamsayP R Jackson
Feb 1, 1989·Journal of Applied Physiology·K J MikinesH Galbo
Mar 1, 1969·Circulation·B N ChiangF H Epstein
Dec 1, 1993·Journal of Consulting and Clinical Psychology·R W JefferyM Mullen
May 22, 1996·JAMA : the Journal of the American Medical Association·W B Kannel
Feb 1, 1997·Diabetologia·J ErikssonV A Koivisto
Feb 1, 1997·Nutrition·B L Feuerstein, R S Weinstock
May 9, 1998·Journal of Applied Physiology·R J BarnardJ J Berger
Jul 20, 1999·Journal of Applied Physiology·J J Berger, R J Barnard
Aug 5, 1999·The New England Journal of Medicine·W C WillettG A Colditz
Nov 28, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M PirlichM Plauth
Jan 4, 2001·The New England Journal of Medicine·F M SacksUNKNOWN DASH-Sodium Collaborative Research Group
May 23, 2001·Hypertension·C K RobertsR J Barnard
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jul 14, 2001·The American Journal of Clinical Nutrition·E ObarzanekUNKNOWN DASH Research Group
Jan 16, 2002·JAMA : the Journal of the American Medical Association·Earl S FordWilliam H Dietz
Jun 6, 2002·Lancet·Raymond J Gibbons

❮ Previous
Next ❯

Citations

Mar 29, 2011·Metabolic Syndrome and Related Disorders·Jongkyu KimHyun-Chul Cho
Jan 24, 2009·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Hussein N YassineJohn P Kirwan
Apr 30, 2009·Annual Review of Nutrition·Faidon MagkosChristos S Mantzoros
Jan 5, 2011·Frontiers in Bioscience (Scholar Edition)·Kristen M Beavers, Barbara J Nicklas
Dec 19, 2013·International Journal of Endocrinology and Metabolism·Fereidoun AziziUNKNOWN Members of Tehran Lipid and Glucose Study Group
Jul 31, 2013·Journal of Clinical Lipidology·Harold E BaysVarman T Samuel
Sep 21, 2010·International Journal of Cardiology·Alberto CorderoJosé R González-Juanatey
Dec 22, 2009·Nutrition·Maria Cristina EliasJoão Prola Netto
Oct 11, 2005·Physical Medicine and Rehabilitation Clinics of North America·David D Kilmer, Holly H Zhao
Nov 8, 2005·Archives of Physical Medicine and Rehabilitation·David D KilmerSusan Aitkens
Feb 15, 2012·The Biochemical Journal·Prerna Bhargava, Chih-Hao Lee
Mar 19, 2014·Journal of Diabetes Mellitus·Daniel C BenyshekCeleste Giordano
Apr 15, 2011·Metabolism: Clinical and Experimental·Seon Mee KimChristos S Mantzoros
Nov 28, 2007·International Quarterly of Community Health Education·Naomi N ModesteSee Wei Toh
Jul 27, 2007·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Eberhard WindlerBirgit-Christiane Zyriax
Jan 8, 2015·Journal of Evidence-based Complementary & Alternative Medicine·Siavash BabajafariArman Zargaran
Jan 8, 2009·Medicine and Science in Sports and Exercise·Joseph E DonnellyUNKNOWN American College of Sports Medicine
Apr 12, 2006·Menopause : the Journal of the North American Menopause Society·Claudia M M MarquesMarcia B Aguila
Jul 25, 2006·Expert Opinion on Investigational Drugs·Marcio C Mancini, Alfredo Halpern
Aug 4, 2009·Cadernos de saúde pública·Priscila Ribas de Farias CostaNedja Silva Santos
Oct 19, 2013·Einstein·Caroline Macoris ColomboJosé Rocha Faria-Neto
Mar 9, 2010·Journal of Neurologic Physical Therapy : JNPT·Marilyn J Mackay-LyonsJonathan Howlett
Jun 3, 2020·Pediatric Gastroenterology, Hepatology & Nutrition·Helen H WangDavid Q-H Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.